Reviewing Choices of Topical Corticosteroids for Modulating Inflammatory Response in Chronic Wound Management
Main Article Content
Abstract
Chronic wounds, characterized by prolonged inflammatory responses and impaired healing, pose a significant challenge in clinical practice. This review explores the potential of topical glucocorticosteroids in modulating inflammation and promoting wound healing in chronic wounds. We delve into the mechanisms underlying chronic inflammation, emphasizing the crucial role of proinflammatory cytokines, reactive oxygen species, and impaired cellular responses. Topical corticosteroids, known for their anti-inflammatory, anti-mitotic, and immunosuppressive properties, emerge as promising candidates to influence the transition from the inflammatory to the proliferative phase of wound healing.
The discussion encompasses the mechanisms of action of topical corticosteroids, focusing on their binding to glucocorticoid receptors, inhibition of inflammatory mediators, and potential adverse effects. We address the importance of selecting the appropriate corticosteroid based on potency, application duration, and patient-specific factors. Various formulations, such as ointments, creams, gels, and foams, are evaluated in terms of their advantages and drawbacks in wound management.
While acknowledging the recognized efficacy of topical corticosteroids in chronic wound management, we highlight concerns regarding their standalone use, such as immunosuppression and potential infection masking. Furthermore, we explore the integration of retinoids with corticosteroids as a novel approach to mitigate unwanted effects and enhance wound healing outcomes. Despite emerging studies on combination therapies, careful consideration and clinical judgment remain paramount for further development and implementation.
In conclusion, this comprehensive review provides insights into the potential of topical corticosteroids in chronic wound management. As research in this field progresses, the integration of innovative therapeutic strategies, including retinoids, holds promise for improving outcomes in the challenging realm of chronic wound care.
Keywords: topical corticosteroids, chronic wound management, inflammation modulation, immunomodulation, retinoids, wound healing outcomes.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Gould L, Abadir P, Brem H, Carter M, Conner-Kerr T, Davidson J, et al. Chronic Wound Repair and Healing in Older Adults: Current Status and Future Research. Journal of the American Geriatrics Society [Internet]. 2015 Mar;63(3):427–38. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582412/
Järbrink K, Ni G, Sönnergren H, Schmidtchen A, Pang C, Bajpai R, et al. The humanistic and economic burden of chronic wounds: a protocol for a systematic review. Systematic Reviews [Internet]. 2017 Jan 24;6(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259833/
Zhao R, Liang H, Clarke E, Jackson C, Xue M. Inflammation in Chronic Wounds. International Journal of Molecular Sciences. 2016 Dec 11;17(12):2085.
https://doi.org/10.3390/ijms17122085
Thorne CH, Chung KC, Gosain AK, Gurtner GC, Mehrara BJ, Rubin JP et al. Grabb and Smith's plastic surgery: Seventh edition. Wolters Kluwer Health Adis (ESP), 2013.
Chronic wound care market size, share & covid-19 impact analysis, by type (diabetic ulcers, pressure ulcers, venous leg ulcers, and others), by product (advanced wound dressings, wound care devices, active therapy, and others), by end user (Hospitals & wound clinics and homecare settings & others), and Regional Forecast, 2023-2030 [Internet]. Fortune Business Insight; 2023 [cited 2023 Sept 6]. Available from: https://www.fortunebusinessinsights.com/amp/industry-reports/chronic-wound-care-market-100222
Frykberg RG, Banks J. Challenges in the Treatment of Chronic Wounds. Advances in Wound Care [Internet]. 2015 Sep;4(9):560–82. https://doi.org/10.1089/wound.2015.0635
Nirenjen, Narayanan J, T. Tamilanban, Vetriselvan Subramaniyan, V. Chitra, Neeraj Kumar Fuloria, et al. Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes. Frontiers in Immunology [Internet]. 2023 Jul 27 [cited 2023 Sep 26];14. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414543/
Zhao R, Liang H, Clarke E, Jackson C, Xue M. Inflammation in Chronic Wounds. International Journal of Molecular Sciences [Internet]. 2016 Dec 11;17(12):2085. https://doi.org/10.3390/ijms17122085
Mahmoudi M, Gould L. Opportunities and Challenges of the Management of Chronic Wounds: A Multidisciplinary Viewpoint. Chronic Wound Care Management and Research [Internet]. 2020 Jul;Volume 7:27–36. https://doi.org/10.1089/wound.2015.0635
Gabros S, Zito PM. Topical Corticosteroids Treasure Island (FL): StatPearls Publishing [Internet]. 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532940/
Bosanquet D, Rangaraj A, Richards A, Riddell A, Saravolac V, Harding K. Topical steroids for chronic wounds displaying abnormal inflammation. The Annals of The Royal College of Surgeons of England [Internet]. 2013 May;95(4):291–6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132506/
Stress Signals, Mediated by Membranous Glucocorticoid Receptor, Activate PLC/PKC/GSK-3β/β-catenin Pathway to Inhibit Wound Closure. Journal of Investigative Dermatology [Internet]. 2017 May 1 [cited 2023 Aug 28];137(5):1144–54. Available from: https://reader.elsevier.com/reader/sd/pii/S0022202X16328032?token=3EB145C6B20C8DEDD9CBD731FC2350F40E54C2716DBD2E7AED8CFF464FF40F9759F5126EC4AFAD01B47C6B61AE85E222
Slominski AT, Zmijewski MA. Glucocorticoids Inhibit Wound Healing: Novel Mechanism of Action. Journal of Investigative Dermatology [Internet]. 2017 May;137(5):1012–15
Stacey SK, McEleney M. Topical Corticosteroids: Choice and Application. Am Fam Physician [Internet]. 2021 Mar 15;103(6):337-343. PMID: 33719380.
Douglas WS, Simpson NB. Guidelines for the management of chronic venous leg ulceration. Report of a multidisciplinary workshop. British Journal of Dermatology [Internet]. 1995 Mar [cited 2023 Aug 7];132(3):446–52. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2133.1995.tb08681.x
Marks JG, Cano C, Leitzel K, Lipton A. Inhibition of Wound Healing by Topical Steroids. The Journal of Dermatologic Surgery and Oncology[Internet]. 1983 Oct;9(10):819–21.
Wicke C, Halliday B, Allen D, Roche NS, Scheuenstuhl H, Spencer MM, et al. Effects of steroids and retinoids on wound healing. Archives of Surgery (Chicago, Ill: 1960) [Internet]. 2000 Nov 1;135(11):1265–70. Available from: https://pubmed.ncbi.nlm.nih.gov/11074878/
Hewish J. Guidelines for the effective diagnosis and management of local wound bed infection and bacterial colonisation. Oxford Health. NHS Foundation Trust, 2016
Oluwole DO, Coleman L, Buchanan W, Chen T, La Ragione RM, Liu LX. Antibiotics-Free Compounds for Chronic Wound Healing. Pharmaceutics. 2022 May 9;14(5):1021. https://doi.org/10.3390/pharmaceutics14051021